Zymeworks (ZYME) Research & Development (2021 - 2026)

Zymeworks has disclosed Research & Development across 6 years of filings, most recently posting $34.5 million for Q1 2026.

• Research & Development for Q1 2026 came in at $34.5 million, down 3.58% year-over-year; the trailing twelve-month figure through Mar 2026 was $135.7 million (down 1.88% YoY), and the FY2025 annual result was $137.0 million, up 1.77% from the prior year.
• Research & Development came in at $34.5 million for Q1 2026 at Zymeworks, up from $31.2 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $62.5 million in Q1 2022 to a low of $25.5 million in Q4 2023.
• The 5-year median for Research & Development is $35.7 million (2025), against an average of $38.7 million.
• Across the five-year window, Research & Development plunged 51.81% in 2023 and jumped 45.21% in 2024, its largest moves.
• Zymeworks' Research & Development stood at $53.0 million in 2022, then slumped by 51.81% to $25.5 million in 2023, then surged by 45.21% to $37.1 million in 2024, then decreased by 15.72% to $31.2 million in 2025, then rose by 10.32% to $34.5 million in 2026.
• The last three Research & Development figures came in at $34.5 million (Q1 2026), $31.2 million (Q4 2025), and $35.6 million (Q3 2025), per Business Quant data.